Global Hepatitis E Diagnostic Tests Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global Hepatitis E diagnostic tests market in its upcoming report titled, “Global Hepatitis E Diagnostic Tests Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global Hepatitis E diagnostic tests market is estimated to register a CAGR of XXX% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global Hepatitis E diagnostic tests market report has been segmented on the basis of test type, end user and region.

Request Covid - 19 Impact

Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis in the world mainly affecting the liver. HEV is transmitted through food and water contamination. Hepatitis E is considered as travel-associated infection. Diagnosis of HEV is based on the detection of viral RNA in the serum or faeces. There is no specific treatment for hepatitis E. Analysis of HEV are performed on RNA in biologic specimens such as stools, serum, and liver biopsy used for diagnosis. Good personal hygiene, high quality public water supplies, proper disposal of sanitary waste and food safety are the most important means of prevention of hepatitis virus. According to WHO, in 2015 Hepatitis E caused approximately 44,000 deaths worldwide. According to WHO statistics, every year there are an estimated 20 million HEV infections worldwide.

Key driver of the global Hepatitis E diagnostic tests market is increasing incidence of hepatitis–e disease. In addition, market in various region rising scarcity of potable water, poor nutrition, government initiative regarding awareness of Hepatitis E diagnosis, increases tourism are the factors anticipated to propel growth of the global Hepatitis E diagnostic tests market. However, high cost of diagnostics procedure and poor reimbursement policies may hinder growth of global Hepatitis E diagnostic tests market.

Government and health authority of various countries are taking initiative and funding hospitals and clinics for making diagnostic test available in the countries. A World Health Organization (WHO) is focusing on making vaccine and diagnostic test available to reduce the global burden of disease. A vaccine to prevent hepatitis E virus infection has been developed and is licensed in China, but is not yet available elsewhere. Major players are collaborating for R&D, so as to develop the vaccine for Hepatitis E disease.

The market in Asia Pacific is expected to dominate market of the global Hepatitis E diagnostic tests market, due to increasing incidence of Hepatitis E in some countries such as Nepal, Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand, and Bhutan of this region. According to WHO statistics, approximately 14 million cases of hepatitis E infection occur annually in the region, which accounts for more than half the global burden. The market in Middle East & Africa is expected to be emerging market of the global Hepatitis E diagnostic tests market. Some countries such as Kenya, Uganda, Nigeria, and Morocco due to poor hygienic conditions, limited access to safe drinking water, and lack of sanitation increasing the incidence of Hepatitis E disease, in lead fuelling the global Hepatitis E diagnostic tests market.

Global Hepatitis E Diagnostic Tests Market Segmentation:

Segmentation by test type:

• ELISA HEV IgM test kits
• ELISA HEV IgG test kits
• RT-PCR test kits

Segmentation by end user:

• Hospital
• Diagnostic laboratory
• Research center
• Point of care

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Hoffmann-La Roche Ltd.
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
• Fast-track diagnostics Ltd.
• Altana Diagnostics GmbH
• Fortress Diagnostics Ltd.
• Mikrogen GmBH
• Abbott Laboratories
• Siemens Ag
• MP Biomedicals LLC
• Primerdesign Ltd.